64 abstracts found.



Leukemic stem cell interactions with the microenvironment: Friend or foe?

Year:

Session type:

Theme:

Dominique Bonnet1
1The Francis Crick Institute

Long non-coding RNAs – Messages from the dark matter of the cancer genome

Year:

Session type:

Theme:

Sven Diederichs1
1University of Freiburg and German Cancer Research Center (DKFZ)

Control of cell division by long non-coding RNAs

Year:

Session type:

Theme:

Duncan Odom1
1University of Cambridge

Long non-coding RNAs and the regulation of the immune response

Year:

Session type:

Theme:

Mark Lindsay1
1University of Bath

Cancer prevention at the population level: Standardised packaging

Year:

Session type:

Theme:

Ann McNeill1
1King’s College London and the UK Centre for Tobacco

Minimum unit pricing for alcohol: The most cost-effective cancer prevention strategy of all?

Year:

Session type:

Theme:

Tim Stockwell1
1Centre for Addictions Research of British Columbia, University of Victoria

Image quantification: Do numbers help treatment stratification?

Year:

Session type:

Theme:

Alan Jackson1
1University of Manchester

Therapeutic targeting of childhood medulloblastoma: strategies for blocking recurrence

Year:

Session type:

Theme:

Sheila Singh1
1McMaster University

Integrating stem and progenitor cell contribution to intestinal self renewal

Year:

Session type:

Theme:

Douglas Winton1
1Cancer Research UK Cambridge Institute

In search for the lacking driver genes of neuroblastoma

Year:

Session type:

Theme:

Rogier Versteeg1
1Netherlands Bioinformatics Centre

Cancer prevention at the population level: Policies to prevent and treat obesity

Year:

Session type:

Theme:

Susan Jebb1
1University of Oxford

HPV vaccines – how to get the maximum protection

Year:

Session type:

Theme:

Margaret Stanley1
1University of Cambridge

The management of oropharynx cancer in the HPV era

Year:

Session type:

Theme:

Terry Jones1
1Institute of Translational Medicine, University of Liverpool

Sentinal lymph node biopsy in head and neck cancer: Good ideas need proper trials

Year:

Session type:

Theme:

Mark McGurk1
1King’s College London and Guy’s and St Thomas’ Foundation Trust

Exploiting functional information in imaging for decision making in clinical practice

Year:

Session type:

Theme:

Christina Messiou1
1The Royal Marsden Hospital

Molecular imaging for targeted therapy

Year:

Session type:

Theme:

Arturo Chiti1
1Humanitas University

Plasma DNA for early cancer screening

Year:

Session type:

Theme:

Yuk Ming Dennis Lo1
1The Chinese University of Hong Kong

Prostate cancer screening as national programme: Benefits at less harm and less cost

Year:

Session type:

Theme:

Harry J. de Koning1
1Erasmus Medical Center, Rotterdam

Precision early diagnosis for oesophageal cancer

Year:

Session type:

Theme:

Rebecca Fitzgerald1
1MRC Cancer Cell Unit, University of Cambridge

Genome-epigenome interplay in medulloblastoma

Year:

Session type:

Theme:

Paul Northcott1
1St. Jude Children's Research Hospital

Translocations and catastrophe – chromothriptic disruption of transcription factors in ependymoma

Year:

Session type:

Theme:

Richard Gilbertson1
1Cancer Research UK Cambridge Institute

Deep sequencing of circulating tumour DNA for personalised cancer detection and monitoring

Year:

Session type:

Theme:

Maximilian Diehn1
1Stanford University

The versatility of CTCs as a liquid biopsy: Biomarkers, biology and drug development

Year:

Session type:

Theme:

Caroline Dive1
1Cancer Research UK Manchester Institute

Using circulating tumour DNA to improve the management of metastatic castration-resistant prostate cancer

Year:

Session type:

Theme:

Gerhardt Attard1
1The Institute of Cancer Research

The contribution of genomic instability to malignant growth in Drosophila

Year:

Session type:

Theme:

Cayetano Gonzalez1
1IRB-Barcelona and BIST

Aneuploidy as the large adaptive mutation: Mechanism and theory

Year:

Session type:

Theme:

Rong Li1
1Johns Hopkins University School of Medicine

Rhabdovirus based oncolytic virus vaccines

Year:

Session type:

Theme:

John Bell1
1Ottawa Hospital Research Institute

Systemic delivery of Enadenotucirev, a Group B oncolytic Adenovirus for the treatment of cancer

Year:

Session type:

Theme:

Kerry Fisher1
1University of Oxford

How should we combine oncolytic virotherapy with other agents?

Year:

Session type:

Theme:

Kevin Harrington1
1The Institute of Cancer Research

Targeting the androgen receptor in prostate cancer: A resilient foe

Year:

Session type:

Theme:

Peter Nelson1
1Fred Hutchinson Cancer Research Center

Targeting tumour-infiltrating myeloid cells for prostate cancer therapy

Year:

Session type:

Theme:

Andrea Alimonti1
1Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI)

Molecularly stratified therapeutic strategies for lethal prostate cancer

Year:

Session type:

Theme:

Johann de Bono1
1The Institute of Cancer Research

Drug discovery and development to overcome cancer evolution and drug resistance

Year:

Session type:

Theme:

Paul Workman1
1The Institute of Cancer Research

DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer

Year:

Session type:

Theme:

Nnenna Kanu1
1UCL Cancer Institute

Mutational signatures and cancer evolution

Year:

Session type:

Theme:

Serena Nik-Zainal1
1Wellcome Trust Sanger Institute

Loss of primary cilia and tissue hyperplasia associated with centrosome amplification

Year:

Session type:

Theme:

David Glover1
1University of Cambridge

Which pro-survival BCL-2 family member should be targeted for the treatment of which cancer?

Year:

Session type:

Theme:

Andreas Strasser1
1The Walter and Eliza Hall Institute

Identifying human cancers to target with BCL-2 inhibition

Year:

Session type:

Theme:

Anthony Letai1
1Dana-Farber Cancer Institute

Harnessing the complex relationship between mitosis and cell death

Year:

Session type:

Theme:

Pascal Meier1
1The Institute of Cancer Research

Why don’t drug companies provide access to drug for use in combination with RT?

Year:

Session type:

Theme:

Anthony Chalmers1
1Glasgow Centre for Cancer Research

The war on prevention: Bellicose cancer metaphors undermine prevention behaviors

Year:

Session type:

Theme:

David Hauser1
1University of Michigan

‘Searching for the new normal’: Exploring the role of language and metaphor in becoming a cancer survivor

Year:

Session type:

Theme:

Lynda Appleton1
1Clatterbridge Cancer Centre

Enhancing patient-centred care: Assessment and management of patients’ unmet needs

Year:

Session type:

Theme:

Afaf Girgis1
1University of New South Wales

Human tumor virus infection and immune control in vivo

Year:

Session type:

Theme:

Christian Münz1
1University of Zurich

Future prospects for novel therapeutics for EBV-associated diseases

Year:

Session type:

Theme:

Lawrence Young1
1University of Warwick

Advances in the radiotherapy treatment of SCLC

Year:

Session type:

Theme:

Corinne Faivre-Finn1
1University of Manchester

Pre-clinical mouse models of SCLC to identify and test novel therapies

Year:

Session type:

Theme:

Julien Sage1
1Stanford University

Immunotherapy and radiotherapy

Year:

Session type:

Theme:

Tim Illidge1
1Cancer Research UK Manchester Institute

Novel drug/radiotherapy combinations

Year:

Session type:

Theme:

Philippe Lambin1
1MAASTRO clinic/Maastricht University

The war on cancer: Reflections from a conscientious objector

Year:

Session type:

Theme:

Andrew Graystone1
1Media Futures